Skip navigation
Facebook IPO


Company: Amylin Pharmaceuticals

Amylin Pharmaceuticals : [AMLN  Loading...      ()   ]
Wednesday, 2 May 2012 | Source: Reuters
LONDON (Reuters) - Biotech companies are fighting back in an unequal battle with Big Pharma, helped by a small but powerful cohort of investors who dominate the companies' share registers.
Thursday, 26 Apr 2012 | Source: The Associated Press
Diabetes drug maker Amylin Pharmaceuticals Inc. said Thursday that sales of its new drug Bydureon totaled $6.9 million in the first quarter, missing analysts' estimates.
Monday, 23 Apr 2012 | Source: The Associated Press
Shares of diabetes drug maker Amylin Pharmaceuticals Inc. jumped Monday after a report the company is reaching out to potential buyers about a possible sale.
Monday, 23 Apr 2012 | Source: CNBC.com
Amylin Pharmaceuticals, which spurned a $3.5 billion takeover bid from Bristol-Myers Squibb and is fending off a lawsuit from activist investor Carl Icahn, started reaching out to potential buyers last week, sources familiar with the situation said on Sunday.
Sunday, 22 Apr 2012 | Source: Reuters
NEW YORK (Reuters) - Amylin Pharmaceuticals Inc <AMLN.O>, which spurned a $3.5 billion takeover bid from Bristol-Myers Squibb Co <BMY.N> and is fending off activist investor Carl Icahn, is exploring a sale, sources familiar with the situation said on Sunday.
Wednesday, 28 Mar 2012 | Source: Reuters
Shares of Amylin Pharmaceuticals rose as much as 51 percent on Wednesday after the company rejected a $3.5 billion unsolicited takeover bid from Bristol-Myers Squibb.
Monday, 30 Jan 2012 | Posted By:  | Source: CNBC.com
Stocks cut most of their earlier losses, but still finished in negative territory Monday as ongoing worries over the euro zone debt crisis kept investors from fully jumping in.
Posts |  COMPANY : Amylin Pharmaceuticals
30 Apr 2012
Posted By:ReutersCNBC Stock Blog Europe
AstraZeneca may be lacking both drugs and a CEO, but for brave investors this might be the time to buy the stock... Read More
16 Apr 2012
Posted By:Nathan Sadeghi-NejadCNBC Stock Blog
Why Amylin Pharmaceuticals shareholders should demand transparency and a public explanation of recent takeover talk... Read More
3 Apr 2012
Posted By:Lee Brodie | Rapid Recap
That’s just one of several headlines that came out of Fast Money's exclusive interview with billionaire investor Carl Icahn.... Read More
12 Mar 2012
Posted By:Adam FeuersteinCNBC Stock Blog
After a hot streak, biotech stocks lose value as clinical trials fail... Read More
2 Feb 2012
Shares of the following companies are showing unusual moves in Thursday's trading session.... Read More
VIDEO | COMPANIES : Amylin Pharmaceuticals
Ahead of the Facebook IPO, the company wants to make privacy policies clear and simple, reports CNBC's Julia Boorstin. S...
Cramer shares six stocks to watch, and reveals them in under 60 seconds.
CNBC's Seema Mody reports on the latest details of the FDA advisory panel's review of Arena Pharmaceuticals' anti-obesit...
The FMHR traders share their top trades of the hour. Jonathan Chaplin, Credit Suisse analyst, explains why his firm upgr...
CNBC's Brian Shactman reports JP Morgan shares are down almost 7% in after-hours trading; Yahoo's CEO says he didn't pro...


Current DateTime: 06:05:27 19 May 2012
LinksList Documentid: 23188555



Current DateTime: 06:05:27 19 May 2012
LinksList Documentid: 23188557

Current DateTime: 06:05:26 19 May 2012
LinksList Documentid: 29778428

Current DateTime: 06:05:26 19 May 2012
LinksList Documentid: 29779196

Current DateTime: 06:05:26 19 May 2012
LinksList Documentid: 29779197

Current DateTime: 06:05:26 19 May 2012
LinksList Documentid: 29779199
CNBCCNBC
About CNBC  |  Site Map  |  Video Reprints   |  Advertise  |  Help  |  Contact
Privacy Policy  |     |  Terms of Service  |  Independent Programming Report
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2012 CNBC LLC.  All Rights Reserved.
A Division of NBCUniversal
Thomson ReutersThomson Reuters